NFAT activation by FKBP52 promotes cancer cell proliferation by suppressing p53

被引:0
|
作者
Hanaki, Shunsuke [1 ]
Habara, Makoto [1 ]
Tomiyasu, Haruki [1 ]
Sato, Yuki [1 ]
Miki, Yosei [1 ]
Masaki, Takahiro [1 ]
Shibutani, Shusaku [1 ,2 ]
Shimada, Midori [1 ,3 ]
机构
[1] Yamaguchi Univ, Dept Vet Biochem, Yamaguchi, Japan
[2] Yamaguchi Univ, Dept Vet Hyg, Yamaguchi, Japan
[3] Nagoya Univ, Grad Sch Med, Dept Mol Biol, Nagoya, Japan
基金
日本学术振兴会;
关键词
HSP90-BINDING IMMUNOPHILIN FKBP52; GLUCOCORTICOID-RECEPTOR; ONCOPROTEIN MDM2; EXPRESSION; PROTEIN; MICROTUBULES; PROGRESSION; MODULATION; APOPTOSIS; TARGET;
D O I
10.26508/lsa.202302426
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
FK506-binding protein 52 (FKBP52) is a member of the FKBP family of proline isomerases. FKBP52 is up -regulated in various cancers and functions as a positive regulator of steroid hormone receptors. Depletion of FKBP52 is known to inhibit cell proliferation; however, the detailed mechanism remains poorly understood. In this study, we found that FKBP52 depletion decreased MDM2 transcription, leading to stabilization of p53, and suppressed cell proliferation. We identi fied NFATc1 and NFATc3 as transcription factors that regulate MDM2 . We also found that FKBP52 associated with NFATc3 and facilitated its nuclear translocation. In addition, calcineurin, a well-known Ca 2+ phosphatase essential for activation of NFAT, plays a role in MDM2 transcription. Supporting this notion, MDM2 expression was found to be regulated by intracellular Ca 2+ . Taken together, these findings reveal a new role of FKBP52 in promoting cell proliferation via the NFAT-MDM2-p53 axis, and indicate that inhibition of FKBP52 could be a new therapeutic tool to activate p53 and inhibit cell proliferation.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Long noncoding RNA PURPL promotes cell proliferation in liver cancer by regulating p53
    Fu, Xueyan
    Wang, Yawei
    Wu, Gang
    Zhang, Wanchuan
    Xu, Shaolin
    Wang, Wenqing
    MOLECULAR MEDICINE REPORTS, 2019, 19 (06) : 4998 - 5006
  • [2] Impact of FKBP52 on cell proliferation and hormone-dependent cancers
    Hanaki, Shunsuke
    Shimada, Midori
    CANCER SCIENCE, 2023, 114 (07) : 2729 - 2738
  • [3] FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells
    Maeda, Keisuke
    Habara, Makoto
    Kawaguchi, Mitsuyasu
    Matsumoto, Hiroaki
    Hanaki, Shunsuke
    Masaki, Takahiro
    Sato, Yuki
    Matsuyama, Hideyasu
    Kunieda, Kazuki
    Nakagawa, Hidehiko
    Shimada, Midori
    MOLECULAR ONCOLOGY, 2022, 16 (04) : 940 - 956
  • [4] Neurogenic differentiation factor 1 promotes colorectal cancer cell proliferation and tumorigenesis by suppressing the p53/p21 axis
    Lei, Ke
    Li, Wenfang
    Huang, Can
    Li, Yanjun
    Alfason, Leader
    Zhao, Hezhao
    Miyagishi, Makoto
    Wu, Shourong
    Kasim, Vivi
    CANCER SCIENCE, 2020, 111 (01) : 175 - 185
  • [5] P-TEFb promotes cell survival upon p53 activation by suppressing intrinsic apoptosis pathway
    Wang, Zhijia
    Macakova, Monika
    Bugai, Andrii
    Kuznetsov, Sergey G.
    Hassinen, Antti
    Lenasi, Tina
    Potdar, Swapnil
    Friedel, Caroline C.
    Barboric, Matjaz
    NUCLEIC ACIDS RESEARCH, 2023, 51 (04) : 1687 - 1706
  • [6] Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway
    Zhu, Hanzhang
    Wang, Jingrui
    Yin, Junjie
    Lu, Bei
    Yang, Qijun
    Wan, Yafeng
    Jia, Changku
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 45 (03) : 1121 - 1135
  • [7] Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52
    Joshi, Jugal Bharat
    Patel, Divya
    Morton, Derrick J.
    Sharma, Pankaj
    Zou, Jin
    Bostanthirige, Dhanushka Hewa
    Gorantla, Yamini
    Nagappan, Peri
    Komaragiri, Shravan Kumar
    Sivils, Jeffrey C.
    Xie, Huan
    Palaniappan, Ravi
    Wang, Guangdi
    Cox, Marc B.
    Chaudhary, Jaideep
    MOLECULAR ONCOLOGY, 2017, 11 (04): : 337 - 357
  • [8] SPARC promotes fibroblast proliferation, migration, and collagen production in keloids by inactivation of p53
    Shi, Shanshan
    Li, Qiuchen
    Liu, Yanxin
    Zhang, Rui
    Chen, Huaxia
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2023, 109 (01) : 2 - 11
  • [9] Artemisinin inhibits gastric cancer cell proliferation through upregulation of p53
    Zhang, Hong-Tao
    Wang, Yun-Long
    Zhang, Jie
    Zhang, Qin-Xian
    TUMOR BIOLOGY, 2014, 35 (02) : 1403 - 1409
  • [10] L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells
    Ayroldi, E.
    Petrillo, M. G.
    Bastianelli, A.
    Marchetti, M. C.
    Ronchetti, S.
    Nocentini, G.
    Ricciotti, L.
    Cannarile, L.
    Riccardi, C.
    CELL DEATH AND DIFFERENTIATION, 2015, 22 (01) : 118 - 130